Fusion Antibodies Plc (FAB.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
As of 12:17PM BST. Market open.
Currency in GBp
Valuation measures4
| Market cap (intra-day) | 3.62M |
| Enterprise value | 3.18M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.88 |
| Price/book (mrq) | 2.49 |
| Enterprise value/revenue | 2.02 |
| Enterprise value/EBITDA | -1.15 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.44 |
| 52-week change 3 | -89.30% |
| S&P500 52-week change 3 | 23.06% |
| 52-week high 3 | 50.0000 |
| 52-week low 3 | 3.0200 |
| 50-day moving average 3 | 3.9320 |
| 200-day moving average 3 | 5.0437 |
Share statistics
| Avg vol (3-month) 3 | 1.24M |
| Avg vol (10-day) 3 | 1.31M |
| Shares outstanding 5 | 95.37M |
| Implied shares outstanding 6 | 95.37M |
| Float 8 | 55.99M |
| % held by insiders 1 | 10.37% |
| % held by institutions 1 | 24.43% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in GBP.Fiscal year
| Fiscal year ends | 31 Mar 2023 |
| Most-recent quarter (mrq) | 30 Sept 2023 |
Profitability
| Profit margin | -179.67% |
| Operating margin (ttm) | -262.29% |
Management effectiveness
| Return on assets (ttm) | -62.52% |
| Return on equity (ttm) | -140.93% |
Income statement
| Revenue (ttm) | 1.58M |
| Revenue per share (ttm) | 0.04 |
| Quarterly revenue growth (yoy) | -71.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -2.8M |
| Net income avi to common (ttm) | -2.84M |
| Diluted EPS (ttm) | -0.0900 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 487k |
| Total cash per share (mrq) | 0.01 |
| Total debt (mrq) | 47k |
| Total debt/equity (mrq) | 3.23% |
| Current ratio (mrq) | 3.26 |
| Book value per share (mrq) | 0.02 |
Cash flow statement
| Operating cash flow (ttm) | -2.35M |
| Levered free cash flow (ttm) | -1.15M |
© 2024 Yahoo. All rights reserved.